Future developments in the aminoglycoside group of antimicrobial drugs.
D000042:Absorption; D000328:Adult; D000617:Aminoglycosides / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy / Q000662:veterinary; D002371:Cat Diseases / Q000188:drug therapy; D002415:Cats; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D004283:Dog Diseases / Q000188:drug therapy; D004285:Dogs; D004352:Drug Resistance, Microbial; D005260:Female; D006207:Half-Life; D006734:Horse Diseases / Q000188:drug therapy; D006736:Horses; D006801:Humans; D007700:Kinetics; D013552:Swine; D013553:Swine Diseases / Q000188:drug therapy; D014018:Tissue Distribution
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents